FIELD: medicine. SUBSTANCE: method involves administering pharmaceutical composition comprising Clyoquinol for treating the disease at any stage of its development. EFFECT: enhanced effectiveness of treatment. 14 cl, 1 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679080C1 |
PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679059C1 |
PEPTIDE COMPOUND, USEFUL FOR INHIBITING FORMATION OF AMYLOID PLAQUES | 2011 |
|
RU2588143C2 |
METHOD OF REDUCING AMYLOID DEPOSITION, AMYLOID NEUROTOXICITY AND MICROGLYOSIS BY (-)-ENANTIOMER NILVADIPINE | 2008 |
|
RU2490014C2 |
PHARMACEUTICAL COMPOSITION BASED ON HAEE PEPTIDE FOR TREATING NEURODEGENERATIVE DISEASES | 2019 |
|
RU2709539C1 |
PHARMACEUTICAL COMPOSITION FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASE | 2012 |
|
RU2618412C2 |
COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID DISEASES AND SYNUCLEINOPATHIES | 2009 |
|
RU2501792C2 |
COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DISTURBANCES | 2005 |
|
RU2387453C2 |
HAEE PEPTIDE MAGNESIUM COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784746C1 |
HAEE PEPTIDE ZINC COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784319C1 |
Authors
Dates
2002-11-27—Published
1997-08-08—Filed